Brand Comparison
Mandom vs Rejuran
A head-to-head comparison of two popular K-beauty brands. Which one is right for your skin?
Our Pick
Rejuran
Higher editor rating (8.7 vs 8)
Mandom
Mandom Corporation is the Japanese drugstore conglomerate behind several J-beauty international hero brands: Bifesta Cleansing Lotion (the J-beauty answer to Bioderma micellar water, often cheaper and arguably better), Barrier Repair Face Mask (a sub-$3 sheet mask that punches way above its price), and Lúcido (the Japanese men's care line). Founded in 1927 as Kaneko Kanezo Shoten, Mandom built one of Japan's most successful drugstore skincare portfolios through quiet, functional product development. The brand isn't editorial or aspirational — it's the company that makes the Japanese drugstore basics that show up in every Tokyo convenience store. The Bifesta line in particular has become a J-beauty must-buy through @cosme rankings and TikTok rediscovery.
Pros
- ✓ Bifesta Cleansing Lotion is one of the best-value micellar waters globally
- ✓ Barrier Repair sheet masks are absurd value
- ✓ 100-year Japanese drugstore heritage
- ✓ broad multi-brand portfolio addresses many concerns
Cons
- ✗ multi-brand structure can be confusing internationally
- ✗ limited US/EU distribution outside Asian-import retailers
- ✗ packaging varies wildly across sub-brands
- ✗ some products fragrance-heavy
Rejuran
Rejuran is the consumer-skincare arm of Pharma Research Products, the Korean biopharma company that developed the original Rejuran Healer injectable — the same PDRN (polydeoxyribonucleotide) dermal treatment that's been a staple of Korean aesthetic clinics since 2014. The topical line translates that clinical DNA into daily-use products, anchored by the patented c-PDRN® complex at 0.5% concentration plus proprietary DOT® (Dermal Optimizing Technology) delivery. The Turnover Ampoule is the hero: a lightweight serum that targets fine lines, firmness, and texture with the same salmon-DNA active that made the injectable famous. Rejuran launched at Sephora US in 2024, won the 2025 Olive Young Slow Aging award, and has become the face of the PDRN trend that's dominating K-beauty in 2025–2026. The price point is premium-mid ($45–55), justified by the clinical pedigree and patented delivery system. Worth reaching for if you want the PDRN trend from the company that actually invented it.
